A Detailed Look at Cannabis Sales in California, Oregon, Arizona, Colorado and Nevada
During June, the tenth month after the onset of the vaping crisis and the fourth month of the pandemic impacting the market, sales across the five markets totaled $751.1 million, up 2% from May, which followed a sequential increase of 14% in April. March had spiked to $666.0 million from $579.9 million in February as customers purchased cannabis ahead of store closures and concerns about limitations on access, so clearly cannabis sales are back on track. A rebound in Nevada of 15% from May helped offset some modest sequential declines in Arizona and Oregon, which have been the fastest growing markets. Additionally, June had one less day than May, and sales may have been impacted to some degree by the social unrest during the month.
Overall sales growth from a year ago among the five Western markets ranged from 15% in Nevada to as high as 61% in Arizona. Nevada has been impacted by the tourist slowdown. Oregon continued its strong growth, rising 47%, while Colorado grew 31%. California saw solid growth, increasing 17%. Concentrates represented 23-36% of sales by market, below the 26-38% share of sales in August before the vaping crisis hit.
Here is a closer look at each market, as detailed by BDSA:
Arizona
In June 2020, cannabis sales in Arizona’s medical dispensaries reached $91.3 million, declining two percent from May. Compared to the previous June, sales in Arizona grew by over 61 percent. Year-to-date through June, sales have reached $495 million, increasing by $161.3 million and 48 percent compared to the same period last year.
Flower sales accounted for nearly 49 percent of overall revenue for the month with $44.5 million in sales, declining two percent from May. Pre-rolled Joints, which are tracked as a separate category, accounted for just under four percent of revenue with $3.3 million in sales. Compared to the previous June, Flower sales increased by 69 percent and Pre-rolled Joints increased by 74 percent.
Concentrate sales accounted for about 36 percent of overall revenues with sales totaling $32.5 million in June, remaining steady from the trailing month. Vape products, the largest segment of the Concentrates category, generated $20.6 million in sales, accounting for 64 percent of the Arizona Concentrates market and 23 percent of sales across all categories. Compared to June 2019, sales of Dabbable Concentrates grew by 98 percent, while Vape sales grew by 43 percent.
The Ingestibles category accounted for nearly 11 percent of sales in June with $9.6 million in revenue. Compared to June 2019 and May 2020, sales in the category grew by 45 percent and declined by five percent, respectively. In June, the $8.9 million in sales from Edibles generated nearly 93 percent of Ingestibles sales overall, while Sublinguals made up the remaining seven percent. Compared to the previous June, Edibles sales increased by 57 percent and Sublingual sales decreased by 29 percent.
California
BDSA sales reporting for the month of June reflects the state market of 663 licensed dispensary locations and 286 delivery operators.
In June 2020, cannabis sales for state licensed retailers and delivery services reached $291.6 million, growing by less than one percent from the trailing month and 17 percent compared to June 2019. Year to date, sales in California have reached $1.6 billion, an 11 percent increase compared to the same period in 2019.
Sales from Flower generated $116.6 million in June 2020, accounting for nearly 40 percent of overall revenues. Compared to the trailing month and June 2019, Flower sales grew by one percent and 42 percent, respectively. Pre-rolled Joints, which are tracked as a separate category, accounted for more than ten percent of overall June revenues with $29.4 million in sales.
Concentrates were the second-largest revenue category in June 2020, reaching $89.6 million in sales and accounting for nearly 31 percent of total revenue. Compared to the trailing month and June 2019, sales increased by two percent and stayed about the same, respectively. The $68.6 million in Vape sales accounted for 77 percent of the Concentrates category and 24 percent of the month’s overall sales revenue.
In June 2020, Ingestibles generated $45.9 million in sales, decreasing by two percent from the trailing month. Compared to June 2019, sales of Ingestibles grew by over ten percent. Edibles contributed 86 percent of Ingestibles revenue, while Sublinguals made up the remaining 14 percent. Compared to June 2019, the Edibles and Sublinguals categories grew by 22 percent and declined by 32 percent, respectively.
Colorado
June 2020 was another milestone for the Colorado cannabis market with sales surpassing $200 million for the first time in history. Sales in Colorado’s adult-use and medical dispensaries reached a combined $201.1 million, growing four percent from May. Compared to the previous June, sales increased by nearly 31 percent. Adult-use sales grew by 27 percent from June 2019 while medical sales grew by 45 percent. Year-to-date through June, combined channel sales have reached $989.3 million, increasing 19 percent from the same period last year.
In June, Flower sales accounted for over 48 percent of total monthly revenues, totaling at $97.1 million. Flower sales increased by one percent from the trailing month and grew 53 percent from the previous June. Year-to-date sales have increased by 37 percent in the category over the same period last year. Pre-rolled Joints, which are tracked separately from Flower, generated $11.2 million in sales for June 2020, growing 26 percent from June 2019 and increasing six percent from the trailing month.
The $58.2 million in Concentrate sales during June 2020 represented a 13 percent increase from the previous year and three percent growth from the trailing month. The category accounted for 29 percent of revenue for the month. Vape products, the largest segment within the Concentrates category, reached $27.6 million in June sales, increasing nine percent compared to May but decreasing over one percent from the previous June. The Vape category accounted almost 48 percent of Concentrates’ revenue and 14 percent of overall sales for the month.
In June 2020, sales from Ingestibles generated $29.8 million, a 21 percent increase from June 2019. Compared to the trailing month, sales in the category grew by nearly 13 percent. Edibles generated $28.1 million in monthly sales revenue, contributing over 94 percent to category sales and 15 percent of total revenue for the month. Sublinguals made up the remaining six percent of Ingestibles sales, totaling at $1.7 million for the month.
Nevada
In June, Nevada dispensaries generated $66.8 million in sales. Compared to June of 2019, sales grew by 15 percent. Compared to the trailing month, sales also increased by 15 percent. Year-to-date through June, sales in the market have reached $340 million, growing by nearly one percent compared to the same period last year.
Flower sales accounted for nearly 52 percent of overall June 2020 sales. Sales in the category reached $34.6 million for the month, growing 15 percent from May. Pre-rolled Joints, tracked separately from Flower, accounted for more nearly 11 percent of June sales with $7.2 million in revenue. Compared to June 2019, Flower and Pre-rolled Joints sales have increased by 40 percent and decreased by ten percent, respectively.
Concentrate sales in June reached $15.6 million, accounting for about 23 percent of overall revenue for the month. Compared to the previous June, category sales increased by four percent. Compared to the trailing month, category sales grew by nine percent. Vape products, the largest segment in the Concentrates category, generated $11.6 million for the month, contributing nearly 74 percent to Concentrates revenue and 17 percent to total monthly sales. Compared to May, vape sales increased by nearly 10 percent. Compared to June 2019, vape sales are six percent lower.
Sales in the Ingestibles category accounted for 12 percent of all revenues, totaling $7.8 million in June sales and declining by about five percent from the previous year. Compared to May, category sales grew by ten percent. Edibles made up 89 percent of the Ingestibles category, reaching $7 million in June revenue. Sublingual sales contributed the remaining 11 percent.
Oregon
In June 2020, Cannabis sales in Oregon’s medical and adult-use dispensaries reached a combined $100.3 million. Compared to the trailing month, sales in the Oregon market decreased by about three percent. Compared to June 2019, sales grew by 47 percent overall. Year-to-date sales in Oregon have reached $514.3 million, growing by 38 percent compared to the same period in 2019.
Sales of Flower generated $48.2 million in June 2020, accounting for 48 percent of overall revenues. Compared to the trailing month, Flower sales declined by over two percent. Compared to June 2019, sales increased by 72 percent. Pre-rolled Joints, which are tracked as a separate category, accounted for nine percent of overall revenues with $8.7 million in sales.
Concentrates generated $26.4 million in June sales. Compared to the trailing month, sales in the category declined three percent. Compared to June 2019, sales in the category grew by 29 percent. Vape products, the largest segment in the Concentrates category, generated $14.2 million in June, contributing 54 percent of Concentrates sales and 14 percent of total monthly revenue.
In June 2020, Ingestibles generated over $13.4 million in sales, a four percent decrease from the previous month. Compared to June 2019, sales of Ingestibles grew by 21 percent. Edibles, which made up 82 percent of the Ingestibles category and 11 percent of overall monthly sales, generated $11 million in June 2020.
For readers looking for a deeper look at cannabis markets across these five states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how the BDSA GreenEdge Platform can provide you with unlimited access to the most accurate and actionable data and analysis.
